SCHEDULE: Vanguard Group Adjusts GE HealthCare Ownership Reporting

The Vanguard Group reports zero beneficial ownership in GE HealthCare Technologies Inc. following an internal realignment.

Summary

• The Vanguard Group, Inc. filed an Amendment No. 3 to Schedule 13G for GE HealthCare Technologies Inc. Common Stock.
• As of March 13, 2026, The Vanguard Group reports 0.00 shares beneficially owned, representing 0% of the class.
• This change is a result of an internal realignment on January 12, 2026, where certain subsidiaries and business divisions of The Vanguard Group, Inc. will now report beneficial ownership separately.
• In accordance with SEC Release No. 34-39538, The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these disaggregated entities.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily a procedural update regarding The Vanguard Group's internal reporting structure rather than a reflection of GE HealthCare's performance or a strategic investment decision.

Positives

• NA

Negatives

• NA

Risks

• NA

Future Outlook

NA

Management Comments

• On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.
• The Vanguard Group, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%.

Industry Context

StockSavvy.ai notes that such internal realignments are common among large asset managers like Vanguard, often driven by operational efficiency or regulatory compliance. This specific filing reflects a change in reporting structure rather than a strategic divestment based on GE HealthCare's performance.

Comparison to Industry Standards

• NA

Legal Proceedings

• NA

Related Party Transactions

• NA

Stakeholder Impact

• Shareholders (GE HealthCare): Minimal direct impact, as the underlying holdings by Vanguard's various funds may still exist, just reported differently by their respective subsidiaries.
• Investment Professionals: Provides clarity on Vanguard's updated reporting structure for GE HealthCare shares, indicating a shift in how beneficial ownership is attributed within the Vanguard organization.

Next Steps

• NA

Key Dates

Keywords

Vanguard Group, GE HealthCare Technologies, Schedule 13G, Beneficial Ownership, Investment Adviser, Common Stock, SEC Filing, Institutional Ownership